Covenant Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-7,262
| Closed | -$202K | – | 171 |
|
|
2024
Q1 | $202K | Buy |
7,262
+50
| +0.7% | +$1.39K | 0.03% | 143 |
|
|
2023
Q4 | $208K | Sell |
7,212
-2,925
| -29% | -$88.4K | 0.04% | 149 |
|
|
2023
Q3 | $336K | Sell |
10,137
-141
| -1% | -$4.99K | 0.09% | 128 |
|
|
2023
Q2 | $377K | Sell |
10,278
-1,157
| -10% | -$45K | 0.1% | 126 |
|
|
2023
Q1 | $467K | Sell |
11,435
-2,992
| -21% | -$129K | 0.11% | 122 |
|
|
2022
Q4 | $739K | Sell |
14,427
-1,970
| -12% | -$94.4K | 0.18% | 113 |
|
|
2022
Q3 | $718K | Sell |
16,397
-750
| -4% | -$36.4K | 0.2% | 102 |
|
|
2022
Q2 | $899K | Sell |
17,147
-543
| -3% | -$27.7K | 0.29% | 90 |
|
|
2022
Q1 | $916K | Sell |
17,690
-405
| -2% | -$21K | 0.25% | 90 |
|
|
2021
Q4 | $1.07M | Hold |
18,095
| – | – | 0.28% | 72 |
|
|
2021
Q3 | $778K | Sell |
18,095
-205
| -1% | -$9.08K | 0.23% | 84 |
|
|
2021
Q2 | $717K | Sell |
18,300
-100
| -0.5% | -$3.89K | 0.21% | 85 |
|
|
2021
Q1 | $667K | Sell |
18,400
-1,341
| -7% | -$47.6K | 0.21% | 91 |
|
|
2020
Q4 | $727K | Sell |
19,741
-2,593
| -12% | -$95.1K | 0.24% | 83 |
|
|
2020
Q3 | $778K | Hold |
22,334
| – | – | 0.25% | 81 |
|
|
2020
Q2 | $693K | Sell |
22,334
-2,618
| -10% | -$88.9K | 0.15% | 86 |
|
|
2020
Q1 | $773K | Buy |
24,952
+5,848
| +31% | +$199K | 0.23% | 79 |
|
|
2019
Q4 | $710K | Sell |
19,104
-656
| -3% | -$23.4K | 0.31% | 81 |
|
|
2019
Q3 | $674K | Buy |
19,760
+264
| +1% | +$9.6K | 0.34% | 78 |
|
|
2019
Q2 | $801K | Sell |
19,496
-1,080
| -5% | -$42.9K | 0.42% | 71 |
|
|
2019
Q1 | $829K | Sell |
20,576
-501
| -2% | -$20.1K | 0.44% | 70 |
|
|
2018
Q4 | $881K | Hold |
21,077
| – | – | 0.44% | 70 |
|
|
2018
Q3 | $881K | Sell |
21,077
-632
| -3% | -$24.3K | 0.44% | 70 |
|
|
2018
Q2 | $747K | Sell |
21,709
-299
| -1% | -$10.2K | 0.4% | 77 |
|
|
2018
Q1 | $741K | Buy |
22,008
+2,302
| +12% | +$79.1K | 0.43% | 74 |
|
|
2017
Q4 | $677K | Buy |
19,706
+1,414
| +8% | +$48.2K | 0.39% | 86 |
|
|
2017
Q3 | $620K | Sell |
18,292
-211
| -1% | -$6.78K | 0.38% | 86 |
|
|
2017
Q2 | $590K | Hold |
18,503
| – | – | 0.38% | 88 |
|
|
2017
Q1 | $601K | Sell |
18,503
-2,956
| -14% | -$93.2K | 0.41% | 83 |
|
|
2016
Q4 | $661K | Buy |
+21,459
| New | +$655K | 0.44% | 74 |
|
Other funds holding PFE
Covenant Asset Management's PFE Position: Q2 2024 in Review
Covenant Asset Management sold out of Pfizer (PFE) in Q2 2024, closing a stake of 7,262 shares — an estimated $202K sold.
Covenant Asset Management first reported a position in PFE in Q4 2016 and held it in 30 quarters. The position peaked at $1.07M in Q4 2021. 2,879 funds tracked by Wall St. Rank hold PFE as of Q2 2024.
- Covenant Asset Management reported no remaining Pfizer position as of Q2 2024 after selling out during the quarter.
- Covenant Asset Management sold 7,262 Pfizer shares in Q2 2024, an estimated $202K.
- Covenant Asset Management first reported a position in Pfizer in Q4 2016 and held it in 30 quarters.
- Covenant Asset Management's Pfizer position peaked at $1.07M in Q4 2021.
- 2,879 funds tracked by Wall St. Rank held Pfizer as of Q2 2024.
Based on Covenant Asset Management's 13F filing for Q2 2024, filed 2 Aug 2024.